Suppr超能文献

Sch 29482对清除鼻咽部脑膜炎奈瑟菌携带者体内该菌的效果评估。

Evaluation of Sch 29,482 in the eradication of Neisseria meningitidis from nasopharyngeal carriers.

作者信息

Pugsley M P, Dworzack D L, Sanders C C, Sanders W E

出版信息

Antimicrob Agents Chemother. 1984 Apr;25(4):494-6. doi: 10.1128/AAC.25.4.494.

Abstract

Fifty-eight chronic carriers of Neisseria meningitidis were given 250 mg of Sch 29,482 or placebo orally every 6 h for 4 days. Although 22 of 29 subjects taking Sch 29,482 became culture negative while taking the drug, only five were culture negative 2 weeks posttherapy. There were no significant adverse reactions.

摘要

58名脑膜炎奈瑟菌慢性携带者每6小时口服250毫克Sch 29,482或安慰剂,共服用4天。虽然服用Sch 29,482的29名受试者中有22人在服药期间培养结果转为阴性,但治疗后2周只有5人培养结果为阴性。未出现明显不良反应。

相似文献

本文引用的文献

9
Side effects of minocycline: a double-blind study.米诺环素的副作用:一项双盲研究。
Antimicrob Agents Chemother. 1977 Apr;11(4):712-7. doi: 10.1128/AAC.11.4.712.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验